Jin-Yuh Shew

Title: Jin-Yuh Shew: Innovator in Cancer Therapy

Introduction

Jin-Yuh Shew is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 2 patents, Shew's work focuses on developing novel methods and compositions for the treatment of cancer.

Latest Patents

One of Jin-Yuh Shew's latest patents involves isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy. This invention provides methods and compositions specifically targeting IL-17RB and its ligand IL-17B. The patent discloses potent neutralizing antibodies specific for IL-17RB, along with methods for their manufacture and use. Additionally, the invention includes antisense, RNAi, and shRNA compositions aimed at preventing and treating various cancers, particularly breast cancer and pancreatic cancer. Another significant patent by Shew is related to azatyrosine analogues, which are novel anti-oncogenic compounds. This patent outlines a method for preparing these azatyrosine analogues and includes a pharmaceutical composition containing the compounds.

Career Highlights

Throughout his career, Jin-Yuh Shew has worked with notable institutions, including Academia Sinica. His research has focused on advancing cancer therapies and improving treatment outcomes for patients.

Collaborations

Shew has collaborated with several professionals in his field, including Hui-po Wang and On Lee, who have contributed to his research endeavors.

Conclusion

Jin-Yuh Shew's innovative work in cancer therapy showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective treatments that can significantly impact patient care.